节点文献

长春瑞滨每周方案新辅助化疗治疗乳腺癌18例临床分析

Initial clinical observation of Neo-adjuvant chemotherapy with weekly vinorelbine in treating breast cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 地力木拉提·艾斯木栾梅香阿迪力·买买提明

【Author】 Delimulati·Aisimu, LUAN Mei-xiang,Adli·Maimaitimin (Department of General Surgery , First Affiliated Hospital, Xinjiang Medical University, Urumqi 830054 China)

【机构】 新疆医科大学第一附属医院普外科新疆医科大学第一附属医院普外科 新疆乌鲁木齐830054新疆乌鲁木齐830054

【摘要】 目的:评价长春瑞滨每周方案新辅助化疗治疗乳腺癌的近期疗效和毒副反应。方法:对18例初发单侧乳腺癌用长春瑞滨每周1次,每次25 mg/m2静脉注射,连续给药4周。结果:临床有效率(cCR+cPR)为 61.1%(11/18),无进展病例,毒副反应主要为白细胞下降、恶心、头痛、脱发、静脉炎。结论:长春瑞滨每周方案新辅助化疗治疗乳腺癌是安全有效的方法。

【Abstract】 Objective: To estimate the recent therapcatic effectiveness and side effects of neo-adjuvant chemotherapy with weekly vinorelbine in treating 18 patients suffered from unilateral breast cancer. Methods: Vinorelbine was injected intravenously ones a week 25 mg/m2 each time for four weeks. Results: CCR+ CPR was 61.1%. There was no further developed case. Main side effects were WBC reduction, nausea, headache, baldness and phlebitis. Conclusion: The method is a safe and effestive way in treating breast cancer.

【关键词】 长春瑞滨新辅助化疗乳腺癌
【Key words】 vinorelbineneo-adjuvant chemotherapybreast cancer
  • 【文献出处】 新疆医科大学学报 ,Journal of Xinjiang Medical University , 编辑部邮箱 ,2006年04期
  • 【分类号】R737.9
  • 【下载频次】48
节点文献中: 

本文链接的文献网络图示:

本文的引文网络